Resolute Advisors’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Resolute Advisors’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-22,800	Closed	-$321	–	75
2023 Q4	$321	Buy	+22,800	New	+$321	﹤0.01%	73
2023 Q3	–	Sell	-22,800	Closed	-$545	–	69
2023 Q2	$545	Hold	22,800	–	–	﹤0.01%	65
2023 Q1	$5.24K	Hold	22,800	–	–	﹤0.01%	71
2022 Q4	$2.53K	Hold	22,800	–	–	﹤0.01%	60
2022 Q3	$24K	Hold	22,800	–	–	﹤0.01%	96
2022 Q2	$42K	Hold	22,800	–	–	﹤0.01%	77
2022 Q1	$81K	Hold	22,800	–	–	﹤0.01%	70
2021 Q4	$196K	Hold	22,800	–	–	0.01%	61
2021 Q3	$173K	Buy	+22,800	New	+$192K	0.02%	70

Resolute Advisors's LHDX Position: Q1 2024 in Review

Resolute Advisors sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2024, closing a stake of 22,800 shares — an estimated $321 sold.

Resolute Advisors first reported a position in LHDX in Q3 2021 and held it in 9 quarters. The position peaked at $196K in Q4 2021. 0 funds tracked by Wall St. Rank hold LHDX as of Q1 2024.

Resolute Advisors reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Resolute Advisors sold 22,800 Lucira Health, Inc. Common Stock shares in Q1 2024, an estimated $321.
Resolute Advisors first reported a position in Lucira Health, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
Resolute Advisors's Lucira Health, Inc. Common Stock position peaked at $196K in Q4 2021.
0 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2024.

Based on Resolute Advisors's 13F filing for Q1 2024, filed 10 May 2024.